Overview
The ICD-10 code D68318 is used to classify idiopathic thrombocytopenic purpura, a rare autoimmune disorder characterized by low platelet counts and increased bruising and bleeding.
Also known as immune thrombocytopenic purpura, this condition can affect individuals of all ages, but is most commonly diagnosed in children and young adults.
The exact cause of idiopathic thrombocytopenic purpura is unknown, but it is thought to involve the destruction of platelets by the immune system.
Signs and Symptoms
Patients with idiopathic thrombocytopenic purpura may experience excessive bruising, nosebleeds, and prolonged bleeding from cuts and injuries.
Some individuals may also develop petechiae, small red or purple spots on the skin, as a result of low platelet counts.
In severe cases, patients may experience bleeding in the brain or gastrointestinal tract, which can be life-threatening.
Causes
The exact cause of idiopathic thrombocytopenic purpura is unknown, but it is believed to be an autoimmune disorder in which the immune system mistakenly attacks and destroys platelets.
Some cases have been linked to viral infections, such as hepatitis C or HIV, which can trigger the immune system to attack platelets.
Genetic factors may also play a role in the development of idiopathic thrombocytopenic purpura, as it tends to run in families.
Prevalence and Risk
Idiopathic thrombocytopenic purpura is a rare disorder, with an estimated incidence of 3.3 cases per 100,000 adults per year.
Women are more commonly affected by the condition than men, with a female to male ratio of 2:1.
Children are also at increased risk of developing idiopathic thrombocytopenic purpura, with the peak incidence occurring in young children between the ages of 2 and 4 years old.
Diagnosis
Diagnosing idiopathic thrombocytopenic purpura involves a thorough physical examination, including a review of the patient’s medical history and symptoms.
Blood tests, such as a complete blood count and platelet function tests, are typically used to confirm the diagnosis and assess the severity of the condition.
In some cases, a bone marrow biopsy may be necessary to rule out other potential causes of low platelet counts.
Treatment and Recovery
Treatment for idiopathic thrombocytopenic purpura focuses on increasing platelet counts and reducing the risk of bleeding.
Corticosteroids, such as prednisone, are commonly used to suppress the immune system and reduce platelet destruction.
In severe cases, other treatments such as intravenous immunoglobulin therapy, splenectomy, or thrombopoietin receptor agonists may be recommended.
Prevention
There is currently no known way to prevent idiopathic thrombocytopenic purpura, as the exact cause of the condition is unknown.
However, avoiding known triggers, such as certain medications or viral infections, may help reduce the risk of developing the disorder.
Regular monitoring of platelet counts and following a treatment plan as recommended by a healthcare provider can also help prevent complications associated with idiopathic thrombocytopenic purpura.
Related Diseases
Idiopathic thrombocytopenic purpura is closely related to other autoimmune disorders, such as lupus, rheumatoid arthritis, and autoimmune hemolytic anemia.
Patients with a history of idiopathic thrombocytopenic purpura may be at increased risk of developing other autoimmune conditions later in life.
It is important for individuals with idiopathic thrombocytopenic purpura to be aware of these potential risks and to undergo regular monitoring for other autoimmune diseases.
Coding Guidance
When coding for idiopathic thrombocytopenic purpura using the ICD-10 code D68318, it is important to document the specific type of the disorder, such as acute or chronic, as well as any associated symptoms.
For accurate coding, healthcare providers should also document the underlying cause of the condition, if known, and any treatments or interventions provided to manage the disorder.
Failure to provide detailed documentation may result in coding errors or denials of reimbursement for services rendered.
Common Denial Reasons
Common reasons for denial of claims related to idiopathic thrombocytopenic purpura include lack of medical necessity, incorrect coding, and insufficient documentation.
Healthcare providers should ensure that claims accurately reflect the services provided and include all relevant diagnoses, treatments, and procedures performed.
By addressing these common denial reasons proactively and submitting thorough documentation with claims, providers can help ensure timely reimbursement for services rendered to patients with idiopathic thrombocytopenic purpura.